Research Associate 3
subramanian.isbscience.org/bio/cliff-rostomily/
My research interests include characterizing immunologic cues that shape immune responses using multi-omic modeling, meta-analysis and experimental automation. I am currently undertaking systems-level approaches to study the human immune response to Lyme disease, investigating the link between small changes in NOD1 expression and gastric cancer and investigating cytokine networks in infection and cancer using irregularly sampled longitudinal data. My hobbies are whitewater kayaking, skiing, backpacking, fishing, electronics and brewing cider.
B.S. Biochemistry
B.S. Applied Computational Math Sciences
Certificate in Electrical Engineering Foundations (Completed 2019)
Leah M. Rommereim, Ajay Suresh Akhade, Bhaskar Dutta, Carolyn Hutcheon, Nicolas W.Lounsbury, Clifford C. Rostomily, Ram Savan, Iain D. C. Fraser, Ronald N. Germain, and NaehaSubramanian. A sustained small increase in NOD1 expression promotes ligand-independentoncogenic activity.Science Signaling, In Press. Publisher: Cold Spring Harbor Laboratory_preprint: https://www.biorxiv.org/content/early/2019/01/21/518886.full.pdf.
Yapeng Su, Daniel Chen, Dan Yuan, Christopher Lausted, Jongchan Choi, Chengzhen L. Dai,Valentin Voillet, Venkata R. Duvvuri, Kelsey Scherler, Pamela Troisch, Priyanka Baloni, GuangrongQin, Brett Smith, Sergey A. Kornilov, Clifford Rostomily, Alex Xu, Jing Li, Shen Dong, AlissaRothchild, Jing Zhou, Kim Murray, Rick Edmark, Sunga Hong, John E. Heath, John Earls,Rongyu Zhang, Jingyi Xie, Sarah Li, Ryan Roper, Lesley Jones, Yong Zhou, Lee Rowen, RachelLiu, Sean Mackay, D. Shane O’Mahony, Christopher R. Dale, Julie A. Wallick, Heather A. Algren,Michael A. Zager, Wei Wei, Nathan D. Price, Sui Huang, Naeha Subramanian, Kai Wang,Andrew T. Magis, Jenn J. Hadlock, Leroy Hood, Alan Aderem, Jeffrey A. Bluestone, Lewis L.Lanier, Philip D. Greenberg, Raphael Gottardo, Mark M. Davis, Jason D. Goldman, and James R.Heath. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.Cell, 0(0), October 2020. Publisher: Elsevier.
